microneedle semaglutide Daewoong pushes into patches with phase 1 trial launch in Korea < Pharma < Article certified physician support. Daewoong's semaglutide microneedle patch hits

Predicted probability was used to categorize the test as positive or negative based on a decision threshold of 0.5 (validated for identification of stage: steatosis 1, inflammation 2, ballooning 1 and fibrosis 2)

Of the surveyed physicians, 42% reported that they advise their patients against using compounded GLP-1s for weight loss

Better for individuals with significant weight loss goals, as studies show the injection leads to greater weight loss compared to the oral version

Industry analysts expect increased competition in the South African market as more pharmaceutical companies introduce generic versions of semaglutide over the coming months

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Some patients with IBS-D report fewer rush-to-the-bathroom moments after starting semaglutide, likely thanks to this effect